Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The treatment slightly increased hair growth and was safe for most women.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Baricitinib helps regrow hair in teens with severe alopecia areata.

EE/CMA is more effective than EE/LNG in reducing acne.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.